1606 Corp Financials
1606 Corp (CBDW) reported $0 in revenue for fiscal year 2025, down 100.0% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
The visible mechanic is balance-sheet survival: liabilities keep climbing while liquidity stays near zero.
From FY2023 to FY2025, shares outstanding rose from 58.6M to 472.4M even as cash fell from$48.9K to$0 and liabilities increased from$1.56M to$3.24M , meaning the capital structure changed dramatically without creating a cash buffer.
FY2025 ended with just
Some figures from recent filings were inconsistent and were omitted from this summary.
Financial Health Signals
1606 Corp does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The metrics below are current.
Key Financial Metrics
Earnings & Revenue
1606 Corp generated $0 in revenue in fiscal year 2025. This represents a decrease of 100.0% from the prior year.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Cash & Balance Sheet
1606 Corp held $0 in cash against $2.1M in long-term debt as of fiscal year 2025.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Margins & Returns
None of these metrics is reported for fiscal year 2025.
Capital Allocation
None of these metrics is reported for fiscal year 2025.
CBDW Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 |
|---|---|---|---|---|---|---|---|
| Revenue | N/A | $0-100.0% | $7K+348.8% | $2K-88.5% | $14K-59.1% | $34K-49.8% | $68K |
| Cost of Revenue | N/A | $0-100.0% | $7K+635.0% | $995-92.2% | $13K-41.2% | $22K-58.1% | $52K |
| Gross Profit | N/A | $0+100.0% | -$118-119.4% | $608-48.6% | $1K-90.4% | $12K-23.0% | $16K |
| SG&A Expenses | N/A | N/A | N/A | N/A | $541K+887.4% | $55K-77.5% | $244K |
| Operating Income | N/A | N/A | N/A | N/A | -$540K | N/A | N/A |
| Interest Expense | N/A | N/A | N/A | -$154K | N/A | N/A | N/A |
| Income Tax | N/A | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | N/A | N/A | N/A | N/A | -$540K | N/A | -$228K |
| EPS (Diluted) | — | -$0.01 | -$0.06-100.0% | -$0.03 | N/A | N/A | N/A |
Not reported in any period shown, so not listed: R&D Expenses.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
CBDW Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 |
|---|---|---|---|---|---|---|
| Total Assets | $16K+58.4% | $10K-93.2% | $148K-36.0% | $232K+465.5% | $41K-18.6% | $50K |
| Current Assets | $16K+58.4% | $10K-93.2% | $148K-36.0% | $232K | N/A | N/A |
| Cash & Equivalents | $0-100.0% | $2K-95.8% | $49K-53.4% | $105K+1001.0% | $10K | $0 |
| Inventory | N/A | $0-100.0% | $73K-35.6% | $113K+259.9% | $31K-37.4% | $50K |
| Accounts Receivable | N/A | $0-100.0% | $4K | $0 | $0-100.0% | $82 |
| Total Liabilities | $3.2M+46.8% | $2.2M+41.1% | $1.6M+89.1% | $827K+219.9% | $259K | $0 |
| Current Liabilities | $3.2M+46.8% | $2.2M+41.1% | $1.6M+89.1% | $827K+272.3% | $222K | $0 |
| Long-Term Debt | $2.1M | N/A | $951K | N/A | N/A | N/A |
| Total Equity | -$3.2M-46.8% | -$2.2M-55.2% | -$1.4M-137.8% | -$595K-173.6% | -$218K-532.0% | $50K |
| Retained Earnings | -$8.2M-18.7% | -$6.9M-186.4% | -$2.4M-187.9% | -$841K-179.3% | -$301K | $0 |
Not reported in any period shown, so not listed: Goodwill.
CBDW Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | N/A | N/A | N/A | N/A | -$610K | N/A | -$95K |
| Investing Cash Flow | $0 | $0 | $0+100.0% | -$87K | $0 | $0 | $0 |
| Financing Cash Flow | N/A | N/A | N/A | N/A | $706K | N/A | $95K |
| Dividends Paid | N/A | $0 | $0 | N/A | N/A | N/A | N/A |
Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Share Buybacks.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
CBDW Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 |
|---|---|---|---|---|---|---|
| Gross Margin | N/A | -1.6%-39.6pp | 37.9%+29.5pp | 8.5%-27.8pp | 36.3%+12.7pp | 23.7% |
| Operating Margin | N/A | N/A | N/A | -3872.9% | N/A | N/A |
| Net Margin | N/A | N/A | N/A | -3872.9% | N/A | -335.4% |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | -452.3% |
| Return on Assets | N/A | N/A | N/A | -233.0% | N/A | -452.3% |
| Current Ratio | 0.010.0x | 0.00-0.1x | 0.09-0.2x | 0.28 | N/A | N/A |
| Debt-to-Equity | N/A | N/A | N/A | N/A | N/A | 0.00 |
Not reported in any period shown, so not listed: FCF Margin.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin.
Note: Shareholder equity is negative (-$3.2M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.01), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Where 1606 Corp Ranks
Frequently Asked Questions
What is 1606 Corp's annual revenue?
1606 Corp (CBDW) reported $0 in total revenue for fiscal year 2025. This represents a -100.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is 1606 Corp's revenue growing?
1606 Corp (CBDW) revenue declined by 100.0% year-over-year, from $7K to $0 in fiscal year 2025.
How much debt does 1606 Corp have?
As of fiscal year 2025, 1606 Corp (CBDW) had $0 in cash and equivalents against $2.1M in long-term debt.
What are 1606 Corp's total assets?
1606 Corp (CBDW) had $16K in total assets as of fiscal year 2025, including both current and long-term assets.
What is 1606 Corp's current ratio?
1606 Corp (CBDW) had a current ratio of 0.01 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
Why is 1606 Corp's debt-to-equity ratio negative or not reported?
1606 Corp (CBDW) has negative shareholder equity of -$3.2M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.